ENLIVEN THERAPEUTICS INC

Ticker: ELVN CUSIP: 29337E102 Class: Common Stock

Logos Global Management LP's Holding History (CIK: 0001792126)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 340,000 Value ($000) $5,236 Avg Close $19.92 Range $15.14 - $24.64
Q3 2025
Shares 340,000 Value ($000) $6,960 Avg Close $20.16 Range $17.43 - $24.38
Q2 2025
Shares 350,000 Value ($000) $7,021 Avg Close $18.93 Range $13.30 - $24.11
Q1 2025
Shares 240,000 Value ($000) $4,723 Avg Close $21.52 Range $18.67 - $25.37
Q4 2024
Shares 140,000 Value ($000) $3,150 Avg Close $25.92 Range $21.43 - $30.03
Q3 2024
Shares 495,000 Value ($000) $12,642 Avg Close $23.16 Range $20.63 - $27.67
Q2 2024
Shares 595,000 Value ($000) $13,905 Avg Close $21.05 Range $15.96 - $26.00
Q1 2024
Shares 1,574,220 Value ($000) $26,408 Avg Close $15.34 Range $10.90 - $19.50
Q4 2023
Shares 307,076 Value ($000) $4,250 Avg Close $12.23 Range $9.80 - $15.41
Q3 2023
Shares 307,076 Value ($000) $4,195 Avg Close $16.84 Range $12.38 - $20.77
Q2 2023
Shares 307,076 Value ($000) $6,267 Avg Close $20.21 Range $17.15 - $23.98
Q1 2023
Shares 401,229 Value ($000) $8,787 Avg Close $20.34 Range $14.56 - $25.34